Athina-Myrto Chioni
Overview
Explore the profile of Athina-Myrto Chioni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bou Antoun N, Afshan Mahmood H, Walker A, Modjtahedi H, Grose R, Chioni A
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076427
Primary or acquired resistance to therapeutic agents is a major obstacle in the treatment of cancer patients. Cervical cancer is the fourth leading cause of cancer deaths among women worldwide...
2.
Bou Antoun N, Chioni A
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569598
One of the leading causes of death worldwide, in both men and women, is cancer. Despite the significant development in therapeutic strategies, the inevitable emergence of drug resistance limits the...
3.
Afshan Mahmood H, Tomas Bort E, Walker A, Grose R, Chioni A
FEBS J
. 2021 Dec;
289(12):3440-3456.
PMID: 34951738
Cervical cancer is one of the most frequently diagnosed cancers in women worldwide. While cervical cancer is caused by human papillomavirus (HPV), not all females infected with HPV develop the...
4.
Chioni A, Grose R
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34830836
The pleiotropic effects of fibroblast growth factors (FGFs), the widespread expression of all seven signalling FGF receptors (FGFRs) throughout the body, and the dramatic phenotypes shown by many FGF/R knockout...
5.
Chioni A, Bajwa R, Grose R
Methods Mol Biol
. 2016 Dec;
1487:255-267.
PMID: 27924573
Organotypic models are 3D in vitro representations of an in vivo environment. Their complexity can range from an epidermal replica to the establishment of a cancer microenvironment. These models have...
6.
Coleman S, Bruce C, Chioni A, Kocher H, Grose R
Clin Sci (Lond)
. 2014 May;
127(4):217-31.
PMID: 24780002
FGFR (fibroblast growth factor receptor) signalling plays critical roles in embryogensis, adult physiology, tissue repair and many pathologies. Of particular interest over recent years, it has been implicated in a...
7.
Coleman S, Chioni A, Ghallab M, Anderson R, Lemoine N, Kocher H, et al.
EMBO Mol Med
. 2014 Feb;
6(4):467-81.
PMID: 24503018
Pancreatic cancer is characterised by desmoplasia, driven by activated pancreatic stellate cells (PSCs). Over-expression of FGFs and their receptors is a feature of pancreatic cancer and correlates with poor prognosis,...
8.
Yeste-Velasco M, Mao X, Grose R, Kudahetti S, Lin D, Marzec J, et al.
J Pathol
. 2014 Jan;
232(5):566-77.
PMID: 24407904
Genomic changes affecting tumour suppressor genes are fundamental to cancer. We applied SNP array analysis to a panel of testicular germ cell tumours to search for novel tumour suppressor genes...
9.
Jarosz M, Robbez-Masson L, Chioni A, Cross B, Rosewell I, Grose R
PLoS One
. 2012 Jun;
7(6):e39436.
PMID: 22737238
Fibroblast Growth Factors play critical roles during development, tissue homeostasis and repair by controlling cell proliferation, survival, migration and differentiation. Of the 22 mammalian FGFs, FGF22, a member of the...
10.
Chioni A, Grose R
J Cell Biol
. 2012 Jun;
197(6):801-17.
PMID: 22665522
FGF-10 and its receptors, FGFR1 and FGFR2, have been implicated in breast cancer susceptibility and progression, suggesting that fibroblast growth factor (FGF) signaling may be co-opted by breast cancer cells....